P53-Dependent Transcription and Tumor Suppression Are Not Affected in Set7/9-Deficient Mice

Molecular Cell

Volumn 43, Issue 4, 2011, Pages 673-680

  Lehnertz, Bernhard ^a,b   Rogalski, Jason C ^a   Schulze, Felix M ^a   Yi, Lin ^a   Lin, Shujun ^a   Kast, Jürgen ^a   Rossi, Fabio M V ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

LYSINE; PROTEIN P53;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CANONICAL ANALYSIS; CELL CYCLE ARREST; CELL FUNCTION; GENE; GENOTOXICITY; IN VIVO STUDY; METHYLATION; MOUSE; NONHUMAN; ONCOGENE; PROTEIN FUNCTION; SET7 GENE; SET9 GENE; TRANSCRIPTION REGULATION;

ANIMALS; APOPTOSIS; CELL AGING; CELL CYCLE; GENE EXPRESSION REGULATION; MICE; MICE, INBRED C57BL; PROTEIN METHYLTRANSFERASES; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

MUS;

EID: 80051733367     PISSN: 10972765     EISSN: 10974164     Source Type: Journal    
DOI: 10.1016/j.molcel.2011.08.006     Document Type: Article

References (32)

1. Adams J.M., Harris A.W., Pinkert C.A., Corcoran L.M., Alexander W.S., Cory S., Palmiter R.D., Brinster R.L. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 1985, 318:533-538.
2. Attardi L.D., de Vries A., Jacks T. Activation of the p53-dependent G1 checkpoint response in mouse embryo fibroblasts depends on the specific DNA damage inducer. Oncogene 2004, 23:973-980.
3. Brooks C.L., Gu W. Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation. Curr. Opin. Cell Biol. 2003, 15:164-171.
4. Campaner S., Spreafico F., Burgold T., Doni M., Rosato U., Amati B., Testa G. The methyltransferase Setd7 is dispensable for the p53-mediated DNA damage response. Mol. Cell 2011, 43:681-688. this issue.
5. Chuikov S., Kurash J.K., Wilson J.R., Xiao B., Justin N., Ivanov G.S., McKinney K., Tempst P., Prives C., Gamblin S.J., et al. Regulation of p53 activity through lysine methylation. Nature 2004, 432:353-360.
6. de Stanchina E., McCurrach M.E., Zindy F., Shieh S.Y., Ferbeyre G., Samuelson A.V., Prives C., Roussel M.F., Sherr C.J., Lowe S.W. E1A signaling to p53 involves the p19(ARF) tumor suppressor. Genes Dev. 1998, 12:2434-2442.
7. Egle A., Harris A.W., Bouillet P., Cory S. Bim is a suppressor of Myc-induced mouse B cell leukemia. Proc. Natl. Acad. Sci. USA 2004, 101:6164-6169.
8. Eischen C.M., Weber J.D., Roussel M.F., Sherr C.J., Cleveland J.L. Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis. Genes Dev. 1999, 13:2658-2669.
9. Eischen C.M., Roussel M.F., Korsmeyer S.J., Cleveland J.L. Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis. Mol. Cell. Biol. 2001, 21:7653-7662.
10. Feng L., Lin T., Uranishi H., Gu W., Xu Y. Functional analysis of the roles of posttranslational modifications at the p53 C terminus in regulating p53 stability and activity. Mol. Cell. Biol. 2005, 25:5389-5395.
11. Garrison S.P., Jeffers J.R., Yang C., Nilsson J.A., Hall M.A., Rehg J.E., Yue W., Yu J., Zhang L., Onciu M., et al. Selection against PUMA gene expression in Myc-driven B-cell lymphomagenesis. Mol. Cell. Biol. 2008, 28:5391-5402.
12. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100:57-70.
13. Hanahan D., Wagner E.F., Palmiter R.D. The origins of oncomice: a history of the first transgenic mice genetically engineered to develop cancer. Genes Dev. 2007, 21:2258-2270.
14. Hemann M.T., Zilfou J.T., Zhao Z., Burgess D.J., Hannon G.J., Lowe S.W. Suppression of tumorigenesis by the p53 target PUMA. Proc. Natl. Acad. Sci. USA 2004, 101:9333-9338.
15. Huang J., Berger S.L. The emerging field of dynamic lysine methylation of non-histone proteins. Curr. Opin. Genet. Dev. 2008, 18:152-158.
16. Huang J., Perez-Burgos L., Placek B.J., Sengupta R., Richter M., Dorsey J.A., Kubicek S., Opravil S., Jenuwein T., Berger S.L. Repression of p53 activity by Smyd2-mediated methylation. Nature 2006, 444:629-632.
17. Ivanov G.S., Ivanova T., Kurash J., Ivanov A., Chuikov S., Gizatullin F., Herrera-Medina E.M., Rauscher F., Reinberg D., Barlev N.A. Methylation-acetylation interplay activates p53 in response to DNA damage. Mol. Cell. Biol. 2007, 27:6756-6769.
18. Jimenez G.S., Nister M., Stommel J.M., Beeche M., Barcarse E.A., Zhang X.Q., O'Gorman S., Wahl G.M. A transactivation-deficient mouse model provides insights into Trp53 regulation and function. Nat. Genet. 2000, 26:37-43.
19. Johnson T.M., Attardi L.D. Dissecting p53 tumor suppressor function in vivo through the analysis of genetically modified mice. Cell Death Differ. 2006, 13:902-908.
20. Krummel K.A., Lee C.J., Toledo F., Wahl G.M. The C-terminal lysines fine-tune P53 stress responses in a mouse model but are not required for stability control or transactivation. Proc. Natl. Acad. Sci. USA 2005, 102:10188-10193.
21. Kurash J.K., Lei H., Shen Q., Marston W.L., Granda B.W., Fan H., Wall D., Li E., Gaudet F. Methylation of p53 by Set7/9 mediates p53 acetylation and activity in vivo. Mol. Cell 2008, 29:392-400.
22. Lowe S.W., Schmitt E.M., Smith S.W., Osborne B.A., Jacks T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 1993, 362:847-849.
23. Lubahn D.B., Moyer J.S., Golding T.S., Couse J.F., Korach K.S., Smithies O. Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc. Natl. Acad. Sci. USA 1993, 90:11162-11166.
24. Prives C. Signaling to p53: breaking the MDM2-p53 circuit. Cell 1998, 95:5-8.
25. Schmitt C.A., Fridman J.S., Yang M., Baranov E., Hoffman R.M., Lowe S.W. Dissecting p53 tumor suppressor functions in vivo. Cancer Cell 2002, 1:289-298.
26. Serrano M., Lin A.W., McCurrach M.E., Beach D., Lowe S.W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 1997, 88:593-602.
27. Subramanian K., Jia D., Kapoor-Vazirani P., Powell D.R., Collins R.E., Sharma D., Peng J., Cheng X., Vertino P.M. Regulation of estrogen receptor alpha by the SET7 lysine methyltransferase. Mol. Cell 2008, 30:336-347.
28. Tang Y., Zhao W., Chen Y., Zhao Y., Gu W. Acetylation is indispensable for p53 activation. Cell 2008, 133:612-626.
29. Todaro G.J., Green H. Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines. J. Cell Biol. 1963, 17:299-313.
30. Toledo F., Wahl G.M. Regulating the p53 pathway: in vitro hypotheses, in vivo veritas. Nat. Rev. Cancer 2006, 6:909-923.
31. Vousden K.H., Lu X. Live or let die: the cell's response to p53. Nat. Rev. Cancer 2002, 2:594-604.
32. Zindy F., Eischen C.M., Randle D.H., Kamijo T., Cleveland J.L., Sherr C.J., Roussel M.F. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev. 1998, 12:2424-2433.